Nitric Oxide (NO) Signaling as a Potential Therapeutic Modality Against Psychostimulants

Author(s): Shervin Liddie, Mara A. Balda, Yossef Itzhak.

Journal Name: Current Pharmaceutical Design

Volume 19 , Issue 40 , 2013

Abstract:

Abuse of psychostimulants presents a significant health and social problem worldwide. Traditionally, the dopaminergic system has received much attention for its role in the development and manifestation of addictive behavior. The identification of the close interaction between the dopaminergic and glutamatergic pathway and by extension the nitric oxide (NO) signaling pathway (the nitrergic system) have provided a broader scope on the mechanisms underlying the development of addictive behavior following exposure to cocaine and methamphetamine. NO signaling is associated with the acquisition and maintenance of several behavioral phenotypes induced by cocaine and methamphetamine (METH), as well as in METH-induced dopaminergic depletion. Because it appears that NO signaling influences response to reward, memory formation, and free radical-induced neurotoxicity, pharmacotherapies targeting NO signaling pathway may prove beneficial in the treatment of psychostimulants abuse.

Keywords: Adolescence, adulthood, cocaine, conditioned place preference, dopamine, methamphetamine, neurotoxicity, nitric oxide (NO), psychostimulant, sensitization.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 40
Year: 2013
Page: [7092 - 7102]
Pages: 11
DOI: 10.2174/138161281940131209144527
Price: $58

Article Metrics

PDF: 10